Prostate Cancer Trial, Recruiting NCT06330909 Sponsor: University Hospital Freiburg Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT06330909
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with prostate cancer confirmed by a tissue biopsy (if the biopsy was done more than 12 months ago, a new one may be needed)
  • Your prostate cancer is localised (has not spread to lymph nodes or other parts of the body), and is classed as high-risk, very high-risk, or unfavourable intermediate-risk (confirm with trial site)
  • You have given written agreement to take part in this specific trial
  • You are over 18 years old
  • You have already had both a PSMA-PET scan and a special prostate MRI scan (mpMRI), or a combined PSMA-PET/MRI scan, meeting required standards
  • You are generally well and able to carry out normal daily activities with little or no limitation (confirm with trial site)
  • Your urinary symptom score is 15 or below on a standard questionnaire (confirm with trial site)
  • Your prostate is no larger than 75 ml in size at the time of treatment planning

Who may not be able to join:

  • Your biopsy shows a rare type of prostate cancer cells called neuroendocrine tumour cells
  • You have previously had radiotherapy to your prostate or the pelvic area
  • You have previously had your prostate surgically removed
  • You have previously had any other local treatment directed at part of your prostate
  • If you have started hormone therapy (ADT), more than one month passed between starting it and having your MRI and PSMA-PET scans
  • Your scans show cancer has spread to nearby lymph nodes
  • Your scans show cancer has spread to other parts of the body
  • Your scans show the cancer has grown into nearby organs beyond the prostate (cT4 disease) (confirm with trial site)
  • Your PSA level was higher than 30 ng/ml before starting hormone therapy
  • Your life expectancy is estimated to be less than 5 years
  • You have hip replacements on both sides, or other implants that would significantly affect CT scan image quality
  • You have a medical reason why you cannot have an MRI scan (for example, certain metal implants or a pacemaker)
  • You have had certain prostate surgery (TURP or HoLEP) that left a significant tissue cavity, or you have had this type of surgery within the last 6 months
  • You have a medical condition that could make radiotherapy unsafe, such as active inflammatory bowel disease or paralysis of the limbs
  • You have had another cancer in the last 2 years (except certain non-melanoma skin cancers), or a previous cancer that could significantly affect your 5-year survival
  • You have any other medical reason that would make external beam radiotherapy to the pelvis unsuitable
  • No visible tumour can be identified on your MRI or PSMA-PET scans
  • You have taken part in another interventional clinical trial in the last 30 days
  • You are currently taking part in another interventional clinical trial that could interfere with this one
  • You are not able to understand or make decisions about your participation in the trial
  • You have a known ongoing problem with misuse of medication, drugs, or alcohol
  • There are concerns that you would have significant difficulties with the positioning required for treatment (confirm with trial site)
  • The required radiation dose limits to protect surrounding healthy organs cannot be safely met

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital Freiburg
Registry
ClinicalTrials.gov
Start date
18 August 2022
Est. completion
1 August 2025

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Relapse free survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov